Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.60% | 188.06% | -518.14% | -108.83% | 526.31% |
| Total Depreciation and Amortization | -16.88% | 11.73% | 6.15% | 32.61% | 1.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 464.06% | -110.22% | 1,128.21% | 108.21% | -358.32% |
| Change in Net Operating Assets | -57.63% | -245.12% | 505.83% | -89.25% | 206.59% |
| Cash from Operations | -41.22% | -23.04% | 210.92% | -41.90% | 17.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 70.93% | 26.82% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 70.93% | 28.19% | -- |
| Total Debt Issued | -- | -- | -- | -24.41% | -- |
| Total Debt Repaid | -24.75% | 2.84% | -30.98% | 18.72% | -156.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.02% | 4.78% | -2.81% | -247.15% | -- |
| Cash from Financing | -29.19% | 3.13% | -142.25% | -34.30% | 1,254.47% |
| Foreign Exchange rate Adjustments | 268.00% | -133.63% | 7,333.33% | 101.91% | -15,800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -144.17% | 196.35% | 186.37% | -266.75% | -78.63% |